(Q71879095)
Statements
Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial (English)
van Gelder T
Zietse R
Yzermans JN
Rischen-Vos J
Vaessen LM
1 December 1996